H.R. 8005

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 8005 Introduced in House (IH)]

<DOC>

119th CONGRESS
2d Session
H. R. 8005

To amend the Controlled Substances Act to prohibit certain acts related 
to fentanyl, analogues of fentanyl, and counterfeit substances, and for 
other purposes.

_______________________________________________________________________

IN THE HOUSE OF REPRESENTATIVES

March 19, 2026

Mr. Evans of Colorado introduced the following bill; which was referred 
to the Committee on the Judiciary, and in addition to the Committee on 
Energy and Commerce, for a period to be subsequently determined by the 
Speaker, in each case for consideration of such provisions as fall 
within the jurisdiction of the committee concerned

_______________________________________________________________________

A BILL

To amend the Controlled Substances Act to prohibit certain acts related 
to fentanyl, analogues of fentanyl, and counterfeit substances, and for 
other purposes.

Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the ``Stop Pills That Kill Act''.

SEC. 2. DEFINITION.

In this Act, the term ``counterfeit fentanyl or methamphetamine 
substance'' means a substance that--
(1) contains fentanyl, any analogue of fentanyl, or 
methamphetamine; and
(2) is marketed under, sold under, or falsely bears the 
trademark, trade name, or other identifying mark, imprint, 
number, or any likeness thereof of another product.

SEC. 3. PROHIBITED ACTS.

Section 403(d)(2) of the Controlled Substances Act (21 U.S.C. 
843(d)(2)) is amended, in the matter preceding subparagraph (A), by 
inserting ``, fentanyl, an analogue of fentanyl, or a counterfeit 
substance'' after ``methamphetamine''.

SEC. 4. COMPREHENSIVE PLAN.

Not later than 180 days after the date of enactment of this Act, 
the Administrator of the Drug Enforcement Administration shall 
establish and implement an operation and response plan to address 
counterfeit fentanyl or methamphetamine substances that includes--
(1) strategies to enable and empower Federal law 
enforcement efforts to investigate and seize counterfeit 
fentanyl or methamphetamine substances;
(2) specific ways that education and prevention efforts to 
stop the use of counterfeit fentanyl or methamphetamine 
substances will be increased, including how--
(A) ongoing efforts, such as Operation Engage, are 
effective in increasing education and prevention; and
(B) how the efforts described in subparagraph (A) 
are tailored to youth and teen access; and
(3) an audit of current campaigns, including the ``One Pill 
Can Kill'' campaign, on counterfeit fentanyl or methamphetamine 
substances, including a review of data and other available 
information on how the campaigns can be tailored, adjusted, or 
improved to better address the flow of counterfeit fentanyl or 
methamphetamine substances.

SEC. 5. REPORT TO CONGRESS.

(a) Report.--Not later than 1 year after the date of enactment of 
this Act, and every year thereafter, the Attorney General, in 
consultation with the Administrator of the Drug Enforcement 
Administration and Director of the Office of National Drug Control 
Policy, shall submit to Congress a report on information regarding the 
collection and prosecutions of counterfeit fentanyl or methamphetamine 
substances.
(b) Contents.--The report required under subsection (a) shall 
include the following:
(1) Data on the aggregate number of counterfeit fentanyl or 
methamphetamine substances seized and collected by Federal law 
enforcement agencies.
(2) A breakdown on how many counterfeit fentanyl or 
methamphetamine substances are in pill form.
(3) A breakdown on which illicit substances are present in 
the counterfeit fentanyl or methamphetamine substances that are 
in pill form.
(4) Data outlining where and when counterfeit fentanyl or 
methamphetamine substances were seized.
(5) Data on the charges filed pursuant to paragraph (1) or 
(2) of section 401(a) of the Controlled Substances Act (21 
U.S.C. 841(a)) in relation to a counterfeit fentanyl or 
methamphetamine substance, particularly in pill form, unless 
disclosure of the data would--
(A) require unsealing an indictment; or
(B) undermine investigations and charges brought by 
the Department of Justice.
(6) Data on the convictions and sentences against those who 
are found guilty under paragraph (1) or (2) of section 401(a) 
of the Controlled Substances Act (21 U.S.C. 841(a)) as it 
pertains to counterfeit fentanyl or methamphetamine substances, 
particularly those in pill form.
(7) Any prevention measures that the Department of Justice, 
Drug Enforcement Administration, or Office of National Drug 
Control Policy are undertaking to limit and reduce the spread 
of counterfeit fentanyl or methamphetamine substances in pill 
form, including ongoing public awareness campaigns.
<all>